Number | Mean (±SD) | |
---|---|---|
Demographical data | ||
Sex, % male/female | 26/21 | 55.32/44.68 |
Age, years | 47 | 70.66 (5.06) |
Cognitive assessment | ||
MMSE | 47 | 27.02 (1.78) |
ApoE genotype | ||
ApoE4 carriers, % (yes/no) | 14/32 | 30.43/69.57 |
ApoE allele frequencies (%) | ||
2.3 | 2 | 4.35 |
2.4 | 2 | 4.35 |
3.3 | 30 | 65.22 |
3.4 | 11 | 23.91 |
4.4 | 1 | 2.17 |
MRI | ||
*Total gray matter volume, ml | 47 | 575.76 (55.50) |
*Total hippocampal volume, ml | 47 | 7.47 (0.99) |
AD signature cortical thickness, mm | 47 | 2.73 (0.13) |
*White matter lesion volume, ml | 46 | 13.27 (16.18) |
Total intracranial volume, ml | 47 | 1548.82 (252.08) |
Serum measurements | ||
Trx80, ng/ml | 47 | 19.46 (36.37) |
Inflammatory markers (pg/ml) | ||
IL-1α | 41 | 1465.39 (2558.60) |
IL-1β | 41 | 123.47 (379.81) |
IL-2 | 41 | 65.23 (159.62) |
IL-3 | 32 | 15.93 (9.48) |
IL-4 | 41 | 169.00 (239.26) |
IL-5 | 41 | 57.16 (78.22) |
IL-6 | 41 | 58.17 (57.09) |
IL-7 | 41 | 44.73 (22.54) |
IL-8 | 41 | 58.17 (57.09) |
IL-10 | 41 | 151.23 (165.27) |
IL-12 p40 | 41 | 435.83 (639.53) |
IL-12 p70 | 41 | 130.07 (149.32) |
IL-13 | 41 | 112.00 (157.59) |
IL-15 | 41 | 81.81 (85.99) |
IL-17 | 41 | 77.17 (104.78) |
Interferon-α2 | 41 | 204.32 (149.36) |
Interferon-γ | 41 | 132.48 (178.42) |
Mip-1a | 36 | 43.22 (37.77) |
TNF-β | 41 | 109.24 (146.66) |
Bradykinin | 47 | 6610000 (3870000) |